The short version: This is an archived talk I gave on Salvia divinorum and its active compound salvinorin A: how it’s been used traditionally and non-traditionally, its varied legal status, and what human and animal research suggests about clinical potential. It’s an educational overview of an unusual kappa-opioid psychedelic, not a treatment recommendation or safety guidance.
In 2019 I recorded a short talk making the case that Salvia divinorum deserves more clinical curiosity than it usually gets, not because it’s a proven treatment, but because dismissing it outright throws away real and unusual pharmacology. I’m keeping it here as an archived resource for anyone researching the plant.
Salvia Divinorum and Salvinorin A: Traditional and Non-Traditional Use and Clinical Potential
Could This Legal Psychedelic Help With Addiction and Chronic Pain?
In the talk I walk through Salvia divinorum, a unique psychedelic plant that acts almost exclusively on kappa opioid receptors, and how the research interest in it parallels the questions being asked about MDMA, psilocybin, and ayahuasca.
Salvia divinorum’s legal status varies significantly by state: legal in some, age-restricted in others, and banned outright in about half the country. Check your state’s current law before assuming access. Its mind-altering effects are typically much shorter and, at usual doses, less intense than those other substances, which is part of why it occupies such an unusual legal and clinical position.
The talk covers:
- Traditional and non-traditional use of the plant Salvia divinorum
- Non-traditional use patterns, including reasons for use, legal issues, and subjective effects
- Human subject laboratory research with salvinorin A
- Potential clinical applications drawn from human and animal research
If you want the underlying science in more depth, including how salvinorin A works, how its effects compare to other psychedelics, and what the research does and doesn’t support, that lives in my main piece on Salvia divinorum in psychotherapy.
Frequently Asked Questions
Is Salvia divinorum legal?
It depends where you are. In the United States, Salvia’s legal status varies by state: legal in some, age-restricted in others, and banned outright in roughly half the country. These laws change as legislatures act, so confirm your state’s current rules before assuming anything.
Who is this talk for?
It’s aimed at clinicians, students, and curious readers who want a grounded overview of Salvia divinorum: its traditional roots, its pharmacology, and the state of the research. It’s educational rather than a how-to, and it doesn’t encourage or instruct use.
What makes salvinorin A different from other psychedelics?
Salvinorin A is the only selective kappa opioid receptor agonist known to occur in nature. Where psilocybin and LSD work on serotonin receptors, salvinorin A works on a completely different system, which is why its effects and its research questions are so distinct.
Does Salvia have real clinical potential?
There’s genuine research interest, particularly for the kappa opioid system’s role in mood, substance use, and pain. But most of the therapeutic-potential evidence is preclinical (animal and primate studies), and salvinorin A’s tendency to produce dysphoria complicates simple therapeutic use. It’s a promising area to study, not an established treatment.
Curious about working together? Get in touch.
Peter H. Addy, PhD, LPC, LMHC is a Portland-based licensed psychotherapist specializing in psychedelic-informed and harm-reduction psychotherapy, ketamine-assisted psychotherapy, and chronic pain. His research background includes postdoctoral work at Yale School of Medicine on psychedelic substances. Learn more about my practice →
